CRCA vs. IBIC
CRCA (ProShares Ultra CRCL) and IBIC (iShares iBonds Oct 2026 Term TIPS ETF) are both exchange-traded funds - CRCA is a Leveraged Equities fund actively managed by ProShares, while IBIC is a Inflation-Protected Bonds fund tracking the ICE 2026 Maturity US Inflation-Linked Treasury Index. CRCA is actively managed, while IBIC is passively managed. At a correlation of -0.04, they often move in opposite directions. CRCA charges 0.95%/yr vs 0.10%/yr for IBIC.
Performance
CRCA vs. IBIC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -71.04% return, which is significantly lower than IBIC's 2.57% return.
CRCA
- 1D
- -0.69%
- 1M
- -49.35%
- 6M
- -69.61%
- YTD
- -71.04%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IBIC
- 1D
- 0.02%
- 1M
- 0.33%
- 6M
- 2.45%
- YTD
- 2.57%
- 1Y
- 4.14%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRCA vs. IBIC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -71.04% | -84.67% |
IBIC iShares iBonds Oct 2026 Term TIPS ETF | 2.57% | 1.33% |
Correlation
The correlation between CRCA and IBIC is -0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 7, 2025 | -0.04 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. IBIC — Risk / Return Rank
CRCA
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
IBIC
CRCA vs. IBIC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and iShares iBonds Oct 2026 Term TIPS ETF (IBIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRCA | IBIC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 2.09 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 15.53 | — |
| Martin ratioReturn relative to average drawdown | — | 52.46 | — |
Loading charts...
Drawdowns
CRCA vs. IBIC - Drawdown Comparison
The maximum CRCA drawdown since its inception was -95.56%, which is greater than IBIC's maximum drawdown of -0.90%. Use the drawdown chart below to compare losses from any high point for CRCA and IBIC.
Loading charts...
Drawdown Indicators
| CRCA | IBIC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.56% | -0.90% | -94.66% |
Max Drawdown (1Y)Largest decline over 1 year | — | -0.27% | — |
Current DrawdownCurrent decline from peak | -95.56% | -0.06% | -95.50% |
Average DrawdownAverage peak-to-trough decline | -73.37% | -0.10% | -73.27% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 0.08% | — |
Volatility
CRCA vs. IBIC - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | IBIC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 0.31% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 0.70% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 194.44% | 0.91% | +193.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 194.44% | 1.55% | +192.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 194.44% | 1.55% | +192.89% |
CRCA vs. IBIC - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than IBIC's 0.10% expense ratio.
Dividends
CRCA vs. IBIC - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 7.61%, more than IBIC's 4.62% yield.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 7.61% | 1.06% | 0.00% | 0.00% |
IBIC iShares iBonds Oct 2026 Term TIPS ETF | 4.62% | 4.43% | 4.65% | 0.83% |
Frequently Asked Questions
CRCA and IBIC have a correlation of -0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, IBIC is cheaper at 0.10% per year. The better choice depends on whether you care most about return, fees, risk, or income.
IBIC is cheaper with a 0.10% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 7.61%, compared with 4.62% for IBIC.
CRCA is categorized as Leveraged Equities, while IBIC is Inflation-Protected Bonds. They also come from different issuers: ProShares and iShares. Their fees differ too: 0.95% for CRCA and 0.10% for IBIC.
Find the right allocation for CRCA and IBIC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer